Reletter
Artwork for Diabetes Trial Files

Diabetes Trial Files

TrialFiles

Free bimonthly newsletter that summarizes the most significant, practice-changing diabetes randomized controlled trials, straight to your inbox.

Platform
Substack
PricingOnly free issuesPublishesMonthly
Issues21Founded2 years agoLast Issue3 months ago
Active

Read this Newsletter

diabetestrialfiles.substack.com
Artwork for Diabetes Trial Files

Latest Issues

Diabetes Trial Files Throwback Thursday: Tirzepatide in Obesity, Tirzepatide vs. Semaglutide in T2DM, and Dapagliflozin in HFrEF

Tirzepatide Once Weekly for the Treatment of Obesity

Jastreboff AM et al. NEJM (June 2022)

Bottom Line: This phase 3, double-blind, placebo-controlled trial enrolled 2539 adults with obesity (BMI ≥30, or ≥27 with at least one weight-r...

3 months ago
2

Diabetes Trial Files: Tirzepatide + Basal Insulin, Empa in GDM, and Mifepristone in T2DM + Hypercortisolism

Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS)

Guo L et al. The Lancet Diabetes & Endocrinology (December 2025)

Bottom Line: The SURPASS-CN-INS trial was a phase 3,...

5 months ago

Diabetes Trial Files Throwback Thursday: Intensive Glycemic Therapy in T2DM, Captopril in T1DM Nephropathy, and CABG/PCI vs. OMT in T2DM with CAD

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

Duckworth W et al. NEJM (January 2009)

Bottom Line: This randomized controlled trial, conducted on 1791 military veterans with suboptimal response to therapy...

6 months ago
1

Diabetes Trial Files: Ecnoglutide in Obesity, Lifestyle Interventions for Adults at Higher Risk for GDM, and Fotagliptin + Metformin in T2DM

Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity

Ji L et al. The Lancet Diabetes & Endocrinology (September 2025)

Bottom Line: This phase 3, randomized, double-blind, placebo-cont...

7 months ago
1
1

Diabetes Trial Files Throwback Thursday: Fibrate Add-On to Statins in T2DM, Intensive Glycemic Therapy in T1DM, and Acarbose to Prevent Diabetes in High-Risk Patients

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

The ACCORD Study Group. NEJM (April 2010)

Bottom Line: This randomized controlled trial investigated the use of combination therapy with a statin plus a fibrate (masked...

8 months ago
2

Key Facts

Contact Information
Newsletter Author
Number of Subscribers
Find out how many people subscribe to this newsletter.

Audience Metrics

Subscribers, engagement, traffic and sponsorship for Diabetes Trial Files.

SubscribersEngagement59Monthly Web Visits
Accepts SponsorsEstimated Cost per Ad

Authors

The writers behind this newsletter.

  • TrialFiles

    Free biweekly newsletter for trainees and staff on General Internal Medicine at Sinai Health that summarizes the most significant, practice-changing randomized controlled trials, straight to your inbox.

  • Frequently Asked Questions

    How can I access the email archive for Diabetes Trial Files?

    You can find recent issues that have been published by Diabetes Trial Files on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Diabetes Trial Files have?

    To see how many people subscribe to Diabetes Trial Files, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Diabetes Trial Files?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Diabetes Trial Files as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Diabetes Trial Files?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Diabetes Trial Files using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters related to Diabetes Trial Files?

    Scroll up to where it says Related Newsletters to see other publications like Diabetes Trial Files. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Diabetes Trial Files?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.